Enzon Pharmaceuticals Statistics
Total Valuation
ENZN has a market cap or net worth of 5.91 million. The enterprise value is 5.17 million.
| Market Cap | 5.91M |
| Enterprise Value | 5.17M |
Important Dates
The last earnings date was Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ENZN has 74.21 million shares outstanding.
| Current Share Class | 74.21M |
| Shares Outstanding | 74.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.23% |
| Owned by Institutions (%) | 48.58% |
| Float | 30.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 0.13 |
| P/TBV Ratio | 13.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.98 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 55.71
| Current Ratio | 55.71 |
| Quick Ratio | 55.16 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.94% and return on invested capital (ROIC) is -2.05%.
| Return on Equity (ROE) | -2.94% |
| Return on Assets (ROA) | -2.02% |
| Return on Invested Capital (ROIC) | -2.05% |
| Return on Capital Employed (ROCE) | -3.38% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.61M |
| Employee Count | 1 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ENZN has paid 319,000 in taxes.
| Income Tax | 319,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.58% in the last 52 weeks. The beta is 0.30, so ENZN's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -48.58% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 48.16 |
| Average Volume (20 Days) | 33,338 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.49M |
| Pretax Income | -1.01M |
| Net Income | -2.61M |
| EBITDA | n/a |
| EBIT | -1.49M |
| Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 44.29 million in cash and n/a in debt, giving a net cash position of 44.29 million or 0.60 per share.
| Cash & Cash Equivalents | 44.29M |
| Total Debt | n/a |
| Net Cash | 44.29M |
| Net Cash Per Share | 0.60 |
| Equity (Book Value) | 43.98M |
| Book Value Per Share | 0.01 |
| Working Capital | 43.94M |
Cash Flow
| Operating Cash Flow | -660,000 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ENZN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -44.08% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ENZN has an Altman Z-Score of 5.54 and a Piotroski F-Score of 1.
| Altman Z-Score | 5.54 |
| Piotroski F-Score | 1 |